Speaker: Andrew Blum, MD, PhD, Assistant Professor, Dept. of Medicine, Case Western Reserve University

Title: Oncogenic TGFβ Signaling: A Novel Therapeutic Vulnerability in Esophageal Adenocarcinoma

Zoom link (MyAccess ID required):
https://ucsf.box.com/s/svohjya992j8tcse3vb7ywwcur0es0yf

This seminar is presented by the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC) and HDFCCC Office of Education and Training, and hosted by Matt Stachler, MD, PhD. Learn more about the Cancer Center Friday Seminar Series in Basic and Translational Research: https://cancer.ucsf.edu/seminars